Liver and hepatic duct cancer

Clinical Obstetrics and Gynecology

Volumn 45, Issue 3, 2002, Pages 939-951

  Valea, Fidel A ^a  

^a Long Island Gynecologic Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; DOXORUBICIN; ETHIODIZED OIL; ETHIODIZED OIL I 131; IODINE 131; TAMOXIFEN; UNCLASSIFIED DRUG;

BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CATHETER ABLATION; CLINICAL EXAMINATION; CRYOSURGERY; DIAGNOSTIC IMAGING; HEPATIC DUCT; HUMAN; LABORATORY DIAGNOSIS; LAPAROSCOPIC SURGERY; LIVER CANCER; LIVER CARCINOGENESIS; LIVER LOBECTOMY; LIVER RESECTION; LIVER TRANSPLANTATION; MINIMALLY INVASIVE SURGERY; PARTIAL HEPATECTOMY; REVIEW;

BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; HEPATECTOMY; HEPATIC DUCT, COMMON; HUMANS; INCIDENCE; LIVER NEOPLASMS; NEOPLASM STAGING; PALLIATIVE CARE; RISK FACTORS;

EID: 0036407320     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200209000-00039     Document Type: Review

References (45)

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47.
2. Franco D, Usatoff V. Surgery for cholangiocarcinoma. Hepato-Gastroenterology. 2001;48:53-55.
3. Muir C. et al. Cancer incidence in five continents. IARC Scientific Publications, 1987:88.
4. Steinitz R. Cancer incidence: Jewish migrants to Israel 1961-1981. IARC Scientific Publications, 1989:98.
5. Kew MC, Geddes EW. Hepatocellular carcinoma in rural southern African blacks. Medicine. 1982;61:98-108.
6. Henderson BE, Preston-Martin S, Edmondson HA. Hepatocellular carcinoma and oral contraceptives. Br J Cancer. 1983;48:437.
7. Evans DM, Williams WJ, Kung IT. Angiosarcoma and hepatocellular carcinoma in vinyl chloride workers. Histopathology. 1983;7:377-388.
8. Van Kaick G, Wesch H, Luhrs M, et al. Radiation-induced primary liver tumor in "Thorotrast patients." Cancer Res. 1986;16:100-103.
9. Yarrish RL, Werner BG, Blumberg BS. Association of hepatitis B virus with hepatocellular carcinoma in American patients. Int J Cancer. 1980;26:711-715.
10. Beasley RP. Hepatitis B virus: The major etiology of hepatocellular carcinoma. Cancer. 1988;61:1942-1956.
11. Shiratori Y, Shiita S, Imamura M, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B and C viral infection in Japan. Hepatology. 1995;22:1027.
12. Okuda K. Hepatocellular carcinoma associated with hepatitis B and C virus infections: Are they different? Hepatology. 1995;22:1883.
13. Zaman SN, Melia MW, Johnson RD, et al. Risk factors in the development of hepatocellular carcinoma in cirrhosis: Prospective study of 613 patients. Lancet. 1985;2:1357-1361.
14. Kuper H, Ye W, Broome U, et al. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism and cirrhosis. Hepatology. 2001;34:714-718.
15. Shibata J, Fujiyama S, Satot, et al. Hepatic arterial injection chemotherapy with cisplatin suspended in oily lymphographic agent for hepatocellular carcinoma. Cancer. 1989;64:1586-1594.
16. Cheblowski RT, Tong M, Weissman J, et al. Hepatocellular carcinoma: Diagnostic and prognostic features in North American patients. Cancer. 1984;53:2701-2706.
17. Luna G, Florence L, Johansen K. Hepatocellular carcinoma: 5-Year institutional experience. Am J Surg. 1985;149:591.
18. Fong Y, Kemeny N, Lawrence TS. Cancer of the liver and biliary tree. In DeVita VT, Hellman S, Rosenberg SA, eds. Cancer Principles & Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins, 2001:1162-1203.
19. Joses DB, Korrey DJ. Screening studies and markers. Gastroenterol Clin North Am. 1987;16:563-573.
20. Lieberman HA, Furie BC, Tong MJ, et al. DES - Carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med. 1984;310:1427.
21. Shinagawa T, Ohto M, Kimura K, et al. Diagnosis and clinical features of small hepatocellular carcinomas with emphasis on the utility of the real-time ultrasonography. Gastroenterology. 1984;86:495-502.
22. Ferrucci JT. Liver tumor imaging. Cancer. 1991;67:1189-1195.
23. Stark DD, Wittenberg J, Butch RJ, Ferrucci JT. Hepatic metastases: Randomized controlled comparison of detection with MR imaging and CT. Radiology. 1987;165:399-406.
24. Reinig JW, Dwyer AJ, Miller D, et al. Liver metastases: Detection with MR imaging at 0.5 and 1.5T. Radiology. 1989;170:149-153.
25. The Liver Cancer Study Group of Japan. The general rules of the clinical and pathological study of primary liver cancer. Jpn J Surg. 1989;19:98.
26. Adachi E, Maeda T, Kajiyama K, et al. Factors correlated with portal venous invasion by hepatocellular carcinoma: Univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer. 1996;77:2022.
27. DiBisceglie AM. Hepatitis C and hepatocellular carcinoma. Semin Liver Dis. 1995;15:64.
28. Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 1991;325:675.
29. Cattone M, Turri M, Caltagirone M, et al. Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alpha-fetoprotein: A prospective study. Hepato-Gastroenterology. 1988;35:101.
30. Caturelli E, Bisceglia M, Fusilli S, et al. Cytology versus microhistological diagnosis of hepatocellular carcinoma. Comparative accuracies in the same fine-needle biopsy specimen. Dig Dis Sci. 1996;41:2326.
31. Nagao T, Inoue S, Got OS, et al. Hepatic resection for hepatocellular carcinoma: Clinical features and long term-prognosis. Ann Surg. 1987;205:33-40.
32. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg. 1991;15:270.
33. Iwatsuki S, Starzl TE, Sheahan DA, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg. 1991;214:221.
34. Nagino M, Ando M, Kamiya J, et al. Liver regeneration after major hepatectomy for biliary cancer. Br J Surg. 2001;88:1084-1091.
35. Kim YI, Nakashima J, Tada I, et al. Prolonged normothermic ischemia of human cirrhotic liver during hepatectomy: A preliminary report. Br J Surg. 1993;80:1566.
36. Man K, Fan ST, Ng IO, et al. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg. 1997;226:704.
37. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693.
38. Fong Y, Sun RI, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg. 1999;229:790.
39. Nonami T, Harada A, Kurokawa T, et al. Hepatic resection for hepatocellular carcinoma. Am J Surg. 1997;173:288.
40. Strong RW. Transplantation for liver and biliary cancer. Semin Surg Oncol. 2000;19:189-199.
41. Yokoyama I, Carr B, Saitsult I, et al. Accelerated growth rates of hepatocellular carcinoma after liver transplantation. Cancer. 1991;68:2095.
42. Azagra JM, Goergen MM, Gilbart EM, Jacobs DM. Laparoscopic anatomical (hepatic) left lateral segmentectomy-technical aspects. Surg Endosc. 2000;10:758-761.
43. Leung TW, Lau WY, Ho SK, et al. Final report on a phase II study of combination cisplatin, interferon alpha, doxorubicin and 5-fluorouracil for inoperable hepatocellular carcinoma. Hepatology. 1998;28:227.
44. Chen MF, Jan YY, Wang CS, et al. Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer. 1989;64:2226.
45. Nakajima T, Kondo Y, Miyazaki M, Okui K. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: Histologic classification and modes of spreading. Hum Pathol. 1988;19:1228.